실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-11 · 마지막 7월 13일
AntibodystaleRocheApproved

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

Retinal Neovascularization; Macular Edema · Retinal Neovascularization

#RetinalNeovascularization#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Dan222 + Niraparib (Dan222 + Niraparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleRocheApproved

Rituximab Infusion (Rituximab Infusion)

Multiple Sclerosis · Nephrotic Syndrome

#NephroticSyndrome#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant + Abemaciclib (Amcenestrant + Abemaciclib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 0%임상시험 2상태 RECRUITING
ADCBiologicstalePfizerPhase 3

PF-08046054 (PF-08046054)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT326 (BNT326)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleDavid HoPhase 1

10E8.4/iMab (10E8.4/iMab)

HIV-1-infection · HIV-1-infection

#HIV-1-infection#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

BMD006 (BMD006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
ADCBiologicstaleTCRCure Biopharma Ltd.Phase 2

TC-N201 (TC-N201)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, AMG 386 and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CD19/CD22 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

CD19 Positive; CD22 Positive · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 DISCONTINUED
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

Puxitatug Samrotecan (Puxitatug Samrotecan)

Endometrial Cancer; Malignant Solid Tumour · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD4512 (AZD4512)

B-cell Non-Hodgkin Lymphoma · B-cell Non-Hodgkin Lymphoma

#B-cellNon-HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleGeneQuantum Healthcare (Suzhou)…Phase 1

GQ1001 (GQ1001)

HER2-positive Breast Cancer; HER2-positive Biliary Tract Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Atezolizumab + Trastuzumab + Vinorelbine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
ADCBiologicstaleEli Lilly and CompanyPhase 1

LY4170156 (LY4170156)

Ovarian Neoplasms; Endometrial Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Bicalutamide)

Extramammary Paget Disease; Scrotum Disease · Extramammary Paget Disease

#ExtramammaryPagetDisease#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleRocheApproved

atezolizumab (Tecentriq, Atezolizumab Injection [Tecentriq])

Hepatocellular Carcinoma · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleNovartisPhase 3

Experimental: Secukinumab high dose (Experimental: Secukinumab high dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleAmgenPhase 2

Bemarituzumab (Bemarituzumab)

Adenocarcinoma · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 46.8%임상시험 2상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Nivolumab/rHuPH20)

Melanoma · Melanoma

#Melanoma#Antibody#Phase3#항체#면역항체+2
효능 ORR 0%임상시험 2상태 DISCONTINUED
AntibodystaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+4
임상시험 2상태 ACTIVE
CGTBiologicstaleJanssen Research & Development,…Phase 2

Cell therapy with bispecific antibodies (Cell therapy with bispecific antibodies)

Gynecological Solid Tumors · Gynecological Solid Tumors

#GynecologicalSolidTumors#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 2상태 DISCONTINUED

54 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기